CA 27.29, Serum

Additional Info: Values obtained with different assay methods or kits can not be used interchangeably. CA 27.29 is not to be used as a diagnostic procedure without confirmation of the diagnosis by another established product or procedure.

Useful For:
CA 27.29 is useful to monitor the response to treatment and, if elevated, suggests recurrence in women with stage II or III breast cancer.

Methodology: Immunochemiluminescence

Specimen Requirements:

Preferred Specimen(s)
1 mL serum (minimum volume 0.5 mL)

Serum Separator Tube (SST®)

Refrigerated

Analytical Time:
1 day

Days Set Up: Monday through Friday

CPT Information:
86300 –